Abstract:Aim: Recombiant human telomerase reverse transcriptase (hTERT)-human IL-18(hIL18) was constructed to investigate its expression and biological function in eukaryotic cells. DCs transfected with hTERT-IL18 acquired stronger telomerase activity and were able to elicit an hTERT-specific cytotoxic T lymphocyte CTL response in vitro.Methods: hIL-18 gene fragment was amplified by Polymerase chain reaction (PCR) and TA cloned. The hIL18 gene was then subcloned into eukaryotic expression vector pcDNA3.1(+) containing human TERM via a linker. The sequence of gene fusion was confirmed using both restrictive enzyme digestion and DNA sequencer. The expression vector with gene fusion was transfected into 3T3 cell line with Lipofectamine 2000. ELISA, Western blot, immunofluorescence stain were performed to determine the expression properties of hTERT-hIL18 in 3T3 cells. Its biological effect on the anti-apoptosis was measured by Flow cytometry and its effect on INF-gamma expression was determined using ELISA. After preparation of dendritic cells, hTERT-hIL18, hTERT, hIL-18 expression vectors were transfected into DCs respectively by electroporation to generate hTERT-specific DCs lines. The peripheral blood mononuclear cells PBMCs were stimulated with different DCs lines to create specific CTL. The response of target cell (leukemia cell line-K562 cell) to hTERT-specific CTL was evaluated by LDH release assay.Results: The human IL-18 gene fragment was amplified from the human mononuclear cells and was inserted into pcDNA3.1(+)/hTERT vector successfully. The correct sequence was proved by both restrictive enzyme digestion and sequencing. The correct open reading frame was also verified. Fusion protein of hTERT-hIL18 was effectively expressed in eukaryotic cells, which was detected by both Western-blotting and immunofluorescence stain. The expressed recombinant fusion protein induced similar levels of INF-gamma to that of native IL-18 protein. FCM assay showed that the transfected fusion protein inhibited the apoptosis, which was consistent with the effects of hTERT as a universal tumor associated antigen. CTL assay shows that hTERT-hIL18 and hTERT gene-transfected DCs stimulated T-cell responses that recognized and lysed tumor target cells of high hTERT expression, whereas DCs transfected with hIL-18 gene didn't induced the response of tumor targets lyses.Conclusion: The Recombinant hTERT-hIL18 fusion protein had both biological activity of hTERT and hIL-18, indicating that this rationally designed protein can be further developed as novel tumor therapeutics. DCs transfected with hTERT-IL18 gene were capable of eliciting a stronger hTERT-specific CTL response in vitro.

Construction and identification of fusion gene of NT4-p53(N37)-HA2-TAT

Construction and identification of fusion gene of NT4-p53(N15)-Ant

Construction and Identification of Recombinant Adenovirus Vector Harboring Fusion Gene NT4-p53 (N15)-Ant

Construction and Identification of Recombinant Adeno-Associated Virus Vector Harboring Fusion Gene NT4-Apoptin-HA2-TAT

Construction and Identification of Recombinant Adeno-Associated Virus Vector Mediating the Expression of the Derepressing P73 Peptide-P53 (N37)

[Expression, Purification and Transduction of Tat-p53 Fusion Protein].

Recombinant Lentivirus-Mediated Gene Transfer of NT4-p53 (N15 ) -Ant Inhibits the Growth of Hepatocellular Carcinoma Cells in Vitro

Construction of Eukaryotic Expression Vector of NT4-APOPTIN-HA2-TAT in Secretory Form and Its Effects on the Tumor Cells

[Construction and Expression of Anti-Human CD3 Single Chain Fv Antibody/human P53 Tetramerization Domain Fusion Gene].

Construction of Recombinant Adenovirus Harboring Fusion Gene NT4p53(C22)Ant and Its Killing Effect on HepG2 Tumor Cells

Construction of Expression Vector of Htert- Hil18 Fusion Gene and Induction of Cytotoxic T Lymphocyte Response Against Htert.

Expression of p53-TAT fusion protein and its apoptosis-inducing activity on HepG 2 cells

Construction of expression vector of hTERT/hIL-18 fusion gene in eukaryotic cells and its function]

Expression,purification and Transduction of PTD-p53 Fusion Protein to Hepatocellular Carcinoma Cell

[Constructing the Recombinant of Pet28a-Tat-lacz].

[Construction and identification of procaryotic expression vector of human NIT1 gene].

Construction and Identification of Glypican3 N-terminal Fusion Gene

Construction of expression vector for ABAD-DP fusion gene

Construction of expression plasmid of the mutant PUMA and its expression in Hela cells

[Construction and Antitumor Effect of Recombinant Adenovirus Vector Containing Heterofusion Gene NT4p53(N15)Ant].

Construction and identification of eukaryotic expression vector for mutant PCNA